Development of Therapies against Hepatocellular Carcinoma Stem Cells via Regulation of Autophagy Activity
Project/Area Number |
18K16364
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 55020:Digestive surgery-related
|
Research Institution | Okayama University of Science (2019-2020) Yamaguchi University (2018) |
Principal Investigator |
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2019: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | cancer stem cell / autophagy / PP6 / がん幹細胞 / オートファジー / がん肝細胞 / Protein phosphatase / 肝細胞がん / Beclin 1 |
Outline of Final Research Achievements |
Initially, our plan was to develop an anticancer strategy to specifically inhibit autophagy in cancer stem cells by focusing on the regulatory mechanism of autophagy, which we had previously elucidated. However, as the expression of PP6, a protein phosphatase, was found to be up-regulated in cancer stem cells, I changed the goal of the project, thinking that clarifying the regulatory mechanism would lead to drug discovery targeting cancer stem cells. As a result, we found that PP6 is regulated by autophagy and that PP6 suppresses autophagy.
|
Academic Significance and Societal Importance of the Research Achievements |
これまでにProtein phosphatase 6 (PP6)は、様々ながん種で遺伝子が変異していることや 発現が変化することが報告されており、がんにおいて重要な因子であることは認識されているがPP6発現がどのように制御されているかは全く明らかになっていなかった。本研究によりPP6の発現制御機構の一端が明らかにできたことにより、様々ながん種の発生メカニズムの解明や治療法の開発の一助となることが期待される。
|
Report
(4 results)
Research Products
(17 results)
-
-
-
-
-
[Journal Article] Autophagy regulates levels of tumor suppressor enzyme protein phosphatase 6.2020
Author(s)
Nobuyuki Fujiwara, Shusaku Shibutani, Yusuke Sakai, Toshio Watanabe, Issei Kitabayashi, Hiroko Oshima, Masanobu Oshima, Hisashi Hoshida, Rinji Akada, Tatsuya Usui, Takashi Ohama*, Koichi Sato.
-
Journal Title
Cancer Science
Volume: 111
Issue: 12
Pages: 4371-4380
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Serum LOX-1 is a novel prognostic biomarker of colorectal cancer.2020
Author(s)
Nakashima-Nakasuga C, Hazama S, Suzuki N, Nakagami Y, Xu M, Yoshida S, Tomochika S, Fujiwara N, Matsukuma S, Matsui H, Tokumitsu Y, Kanekiyo S, Shindo Y, Maeda N, Tsunedomi R, Iida M, Takeda S, Yoshino S, Ueno T, Hamamoto Y, Ogihara H, Hoshii Y, Nagano H.
-
Journal Title
Int J Clin Oncol.
Volume: -
Issue: 7
Pages: 1308-1317
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
[Presentation] Elucidation of control mechanism of type 2A protein phosphatase by autophagy2018
Author(s)
Nobuyuki Fujiwara, Shusaku T. Shibutani, Yusuke Sakai, Hiroshi Shima, Toshio Watanabe, Hiroko Ohshima, Masanobu Ohshima, Tathuya Saito, Shizuo Akira, Hiroaki Nagano, Tathuya Usui, Takashi Ohama, Koichi Sato
Organizer
第13回プロテインホスファターゼ国際カンファレンス Workshop on Frontiers in Phosphatase Research and Drug Discovery
Related Report
Int'l Joint Research
-
-
-
[Presentation] RAB3B was identified as a gene involved in characteristics of induced cancer stem-like sphere cells2018
Author(s)
Ryouichi Tsunedomi, Kiyoshi Yoshimura, Satoshi Matsukuma, Nobuyuki Fujiwara, Shinsuke Kanekiyo, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Shigefumi Yoshino, Shoichi Hazama, Tomio Ueno, Hiroaki Nagano
Organizer
第77回日本癌学会学術総会
Related Report